| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.37 | 0.05 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.087 | 0.06 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |